Animation

What Makes a Medical Device MOA Animation Actually Accurate

May 27, 20267 min readBy Vuelab

Most medical device MOA animations look polished, and a lot of them get the science subtly wrong.

Not catastrophically wrong. Not in ways the average viewer would catch. But wrong in the small ways that matter to the engineer who built the device, to the surgeon who’ll use it, to the regulator reviewing the claims, and to the KOL whose name is attached to the marketing.

Vuelab has spent more than a decade building animation work exclusively for MedTech brands, led by a creative team with more than 30 years of combined production experience. After that much time in the category, the pattern is clear: an accurate MOA animation isn’t a render. It’s the cumulative output of a series of decisions a studio either makes well or doesn’t. Here’s what those decisions actually look like.

Accuracy starts with who’s in the discovery call

When a manufacturer comes to us with an animation project, the first thing our team always asks is whether we can get the engineers and scientists on the discovery call. Not instead of the marketing team, the marketing team usually has a great brief and knows the product story cold. But in addition to them. We want time with the people who actually developed the technology.

We’re always open and honest about why. It’s not a trust issue. The marketing team knows the product story. What they don’t always know, and shouldn’t be expected to know in deep detail, is the molecular, mechanical, or thermal story underneath it. What’s actually happening to the tissue. Why this device’s approach is different from a competitor’s at a level the buyer can feel. That deeper story is what turns a clean MOA into a credible one.

Sometimes the engineers speak more scientifically than what’s over our capabilities. That’s fine. It’s still useful educational information, and it always provides the most accuracy in the final work.

We’re MedTech savvy. We are not doctors at the end of the day. The people who built the device know things about it that nobody else knows. Get them on the first call.

It depends on going deep with the right technical reviewer

For some categories, time with the engineering team is enough. For others, especially surgical work, the bar is higher. We need real time with a clinical reviewer who can walk us through the procedure in detail.

The animations that demand the highest accuracy in our category are surgical ones, specifically the ones where a device is actually being implanted into the body. These animations often get used as training content. Other physicians learn from them. If the anatomical relationships are off, if the surgical approach is shown incorrectly, if the device-tissue interaction isn’t right, the studio isn’t just shipping a flawed marketing asset. They’re potentially teaching the wrong thing to the next surgeon who picks up the device.

The work Vuelab did for Nyxoah on their Genio sleep apnea system is the example we come back to most often. We produced a seven-minute animation that walked through how the device is implanted into human anatomy. Seven minutes is long for MOA work. It needed to be that length because the procedure deserved it.

It also took countless calls. Our team worked directly with their chief medical officer to truly understand how the implantation actually works, not in broad strokes, but in the granular detail that lets a studio draw the access angle correctly, sequence the steps in the order they actually happen, and show what a surgeon would see in the OR.

That work crystallized something we now tell every aesthetic, orthopedic, and surgical client at kickoff. There is no shortcut to clinical accuracy. You build it call by call, and the timeline has to reflect that.

It gets locked at storyboards, not in animation

Even with the right people in the room early, accuracy doesn’t survive a chaotic production process. The biggest threat to accuracy is what happens after storyboards get approved and the work starts to move.

When clients are reviewing scripts and static frames, the conversation is contained. Everyone is in planning headspace. When they see the same scenes start to move on screen, everything changes. Suddenly everybody starts putting their Martin Scorsese hats on and asking, "What if you did this? Can we do this? What if we added a shot here?"

That’s the moment scope creep arrives. It’s also where studios get into trouble if the early work hasn’t been done. Once you start building animation, going backwards is expensive. It costs money. It costs time. It costs client confidence. And it can quietly compromise accuracy if a late-stage change breaks the chain of clinical validation already done at the storyboard level.

Our job, before the animation step ever starts, is to over-educate the client during storyboards. We walk through every frame. We talk about pacing. We explain what each shot will look like and feel like when it comes to life. We do everything we can to lock the story before motion begins.

The other moment we protect carefully is the first blocking handoff. That’s when we put the first rough version of the animation in motion in front of the client and ask the simple question: does this represent the storyboards we built together and the story we agreed on? If yes, the project moves forward fast. If something needs to shift, this is the cheapest moment to fix it, before accuracy gets compromised downstream.

It needs a review chain calibrated to where the company is

Who reviews the work, and when, also determines whether accuracy holds. And that varies enormously depending on the company’s stage.

With pre-FDA-approval startups, the review chain is usually short. We’re typically working directly with the founder or the inventor. TYBR Health is a great example, we’re talking to the people who built the technology. Decisions happen fast. Accuracy gets confirmed at the source. The animation can move from kickoff to delivery on a tight schedule because the right person is already in every call.

With publicly traded companies, the shape is completely different. Nyxoah again is the example. Review can run anywhere from two to six weeks because there are clinical, regulatory, marketing, KOL, and executive stakeholders all weighing in. The bar is high, and rightfully so, given the audience and the regulatory environment. Studios that aren’t used to MedTech often misjudge how long this part of the process takes, which puts accuracy at risk when timeline pressure starts hitting the clinical reviewers.

Neither shape is harder than the other. They’re just different. Knowing which one you’re in changes how a studio scopes the project, protects the timeline, and sequences the work so the right reviewer is looking at the right version at the right moment.

It requires execution that matches the device

Accuracy isn’t only whether the science is right. It’s also whether the work feels credible. A device that’s been through years of engineering, clinical trials, and capital to get to market deserves animation that looks like it belongs to that company.

A lot of style choices in MOA animation get this wrong. Simplistic approaches, whiteboard explainers, basic 2D motion graphics, don’t match the level of sophistication a medical device warrants. A high-tech device shouldn’t be visualized the way an introductory educational video would be. It should be visualized the way a technology company would visualize its own product launch. Not over-designed. But unmistakably sophisticated.

When the execution doesn’t match the device, even technically accurate content stops feeling credible. The buyer’s reaction isn’t "the science is right." It’s "this doesn’t feel serious." That perception is its own kind of inaccuracy, because it undersells the work the company has actually done.

It needs the story underneath the science

The last piece, and the one most often missing from work that looks technical but doesn’t land, is story.

A lot of MOA animations are technically dense but never answer the harder question: why was this technology built, and what does it do better than the alternative? Where is the actual differentiator? Those are the questions a buyer leans in for. They’re also the questions that go missing when a studio treats accuracy as a checklist instead of as a narrative.

The Agnes 3D mechanism-of-action animation is a recent example of what happens when this lands, the storyboard, the clinical review, and the execution all aligned at the right depth, and the underlying technology was given as much narrative care as anatomical precision.

Accuracy without story is just a textbook diagram. Story without accuracy is fiction. The work that actually sells a device, and the work that holds up to clinical and regulatory scrutiny, does both.

What accurate MOA work actually is

If we had to summarize: an accurate medical device MOA animation is the cumulative output of a series of decisions made well.

Engineers and scientists in discovery. Clinical reviewers going shot-by-shot when surgical accuracy is on the line. Storyboards locked before motion begins. A review chain that matches the company’s stage. A level of execution that matches the device. And a story underneath the science that explains why the work matters.

You can hire a studio with a beautiful reel and still ship something inaccurate if those decisions weren’t made. You can also hire a less-decorated studio and ship something extraordinary if they were.

The reel is the easiest part of an animation studio to evaluate. The process is what determines whether the work tells the truth.

FAQs

Frequently asked questions.

How do we know if our MOA animation is actually accurate, or just looks accurate?

Look at three things. First: were the engineers and scientists who actually built the device involved in discovery, or only the marketing team? Second: was there a clinical or KOL review pass on the storyboards before animation began? Third: does the work tell a story about why the device matters, not just how it functions? If the answer to any of these is no, the work probably looks polished without holding up under technical scrutiny.

How long does an accurate MOA animation take to produce?

For a single MOA animation, plan for eight to twelve weeks from kickoff to delivery. The biggest variable is the review chain. Pre-FDA-approval startups often move faster because the founder or inventor is in every call. Public companies typically require two to six weeks of clinical, regulatory, and KOL review on top of the production schedule.

If our marketing team has a great brief, do we still need to involve our engineers?

A great marketing brief is essential, and we ask for one early. But it is not a substitute for time with the engineers and scientists who actually built the device. The marketing team knows the product story. The engineers know the molecular, mechanical, or thermal story underneath it. The most accurate MOAs come from studios who get both groups on the discovery calls.

What review process should we plan for an MOA animation?

Plan for review at three stages: script, storyboards, and first blocking. Engineers and scientists should weigh in at the script stage when the narrative is taking shape. Clinical or KOL reviewers should validate the storyboards before any animation begins. The broader marketing, regulatory, and executive review fits naturally at first blocking. Catching issues at each stage costs a fraction of catching them at final animation.

Can an MOA animation be both clinically accurate and persuasive?

Yes, and the ones that sell devices do both. Accuracy without story produces a textbook diagram nobody remembers. Story without accuracy produces marketing that does not hold up under regulatory or KOL scrutiny. The two are not in tension when the right people are in the room from the start of the project.

What is the most common mistake MedTech companies make with MOA animation?

Treating accuracy as a checklist instead of as a process. The pattern we see most often: a marketing-team brief gets handed to a generalist studio, and engineers are pulled in only for final corrections. By that point the storyboards are locked, the budget is largely spent, and the only way to get accurate is to compromise either time, money, or accuracy itself.

Launching a product?
Let’s make it unmissable.

Give us a few minutes, and we’ll show you how to better visualize your product.